List of bibliographic references
Number of relevant bibliographic references: 8.
| Ident. | Authors (with country if any) | Title |
|---|
| 002453 (2007) |
Jacob M. Rowe ; Andreas Hochhaus ; Hagop M. Kantarjian ; Michele Baccarani ; Jeffrey H. Lipton ; Jane F. Apperley ; Brian J. Druker ; Thierry Facon ; Stuart L. Goldberg ; Francisco Cervantes ; Dietger Niederwieser ; Richard T. Silver ; Richard M. Stone ; Timothy P. Hughes ; Martin C. Muller ; Rana Ezzeddine ; Athena M. Countouriotis ; Neil P. Shah | Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. Commentary |
| 002C35 (2008) |
Neil P. Shah ; Hagop M. Kantarjian ; Dong-Wook Kim ; Delphine Rea ; Pedro E. Dorlhiac-Llacer ; Jorge H. Milone ; Jorge Vela-Ojeda ; Richard T. Silver ; H. Jean Khoury ; Aude Charbonnier ; Nina Khoroshko ; Ronald L. Paquette ; Michael Deininger ; Robert H. Collins ; Irma Otero ; Timothy Hughes ; Eric Bleickardt ; Lewis Strauss ; Stephen Francis ; Andreas Hochhaus | Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia |
| 003688 (2010) |
Jorge E. Cortes ; Michele Baccarani ; François Guilhot ; Brian J. Druker ; Susan Branford ; Dong-Wook Kim ; Fabrizio Pane ; Ricardo Pasquini ; Stuart L. Goldberg ; Matt Kalaycio ; Beatriz Moiraghi ; Jacob M. Rowe ; Elena Tothova ; Carmino De Souza ; Marc Rudoltz ; Richard Yu ; Tillmann Krahnke ; Hagop M. Kantarjian ; Jerald P. Radich ; Timothy P. Hughes | Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study |
| 003A07 (2010) |
Giuseppe Saglio ; Dong-Wook Kim ; Surapol Issaragrisil ; Philipp Le Coutre ; Gabriel Etienne ; Clarisse Lobo ; Ricardo Pasquini ; Richard E. Clark ; Andreas Hochhaus ; Timothy P. Hughes ; Neil Gallagher ; Albert Hoenekopp ; MEI DONG ; Ariful Haque ; Richard A. Larson ; Hagop M. Kantarjian | Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia |
| 004D07 (2012) |
Hagop M. Kantarjian ; Xavier G. Thomas ; Anna Dmoszynska ; Agnieszka Wierzbowska ; Grzegorz Mazur ; Jiri Mayer ; Jyh-Pyng Gau ; Wen-Chien Chou ; Rena Buckstein ; Jaroslav Cermak ; Ching-Yuan Kuo ; Albert Oriol ; Farhad Ravandi ; Stefan Faderl ; Jacques Delaunay ; Daniel Lysak ; Mark Minden ; Christopher Arthur | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia |
| 005526 (2013) |
Hagop M. Kantarjian ; Giovanni Martinelli ; Elias J. Jabbour ; Alfonso Ouintas-Cardama ; Kiyoshi Ando ; Jacques-Olivier Bay ; Andrew Wei ; Stefanie Gröpper ; Cristina Papayannidis ; Kate Owen ; Laura Pike ; Nicola Schmitt ; Paul K. Stockman ; Aristoteles Giagounidis | Stage I of a Phase 2 Study Assessing the Efficacy, Safety, and Tolerability of Barasertib (AZD1152) Versus Low-Dose Cytosine Arabinoside in Elderly Patients With Acute Myeloid Leukemia |
| 005A66 (2014) |
Aristoteles Giagounidis ; Ghulam J. Mufti ; Pierre Fenaux ; Mikkael A. Sekeres ; Jeffrey Szer ; Uwe Platzbecker ; Andrea Kuendgen ; Gianluca Gaidano ; Wieslaw Wiktor-Jedrzejczak ; KUOLUNG HU ; Paul Woodard ; Allen S. Yang ; Hagop M. Kantarjian | Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and Thrombocytopenia |
| 005B42 (2014) |
Michele Baccarani ; Brian J. Druker ; Susan Branford ; Dong-Wook Kim ; Fabrizio Pane ; Lidia Mongay ; Manisha Mone ; Christine-Elke Ortmann ; Hagop M. Kantarjian ; Jerald P. Radich ; Timothy P. Hughes ; Jorge E. Cortes ; François Guilhot | Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "KANTARJIAN (Hagop M.)"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i \
-Sk "KANTARJIAN (Hagop M.)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Merge
|type= indexItem
|index= FA11s1.i
|clé= KANTARJIAN (Hagop M.)
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
